CoChat

Senescence-associated-β-galactosidase staining following traumatic brain injury in the mouse cerebrum

Open access

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Primary and secondary traumatic brain injury (TBI) can cause tissue damage by inducing cell death pathways including apoptosis, necroptosis, and autophagy. However, similar pathways can also lead to senescence. Senescent cells secrete senescence-associated secretory phenotype proteins following persistent DNA damage response signaling, leading to cell disorders. TBI initially activates the cell cycle followed by the subsequent triggering of senescence. This study aims to clarify how the mRNA and protein expression of different markers of cell cycle and senescence are modulated and switched over time after TBI. We performed senescence-associated-β-galactosidase (SA-β-gal) staining, immunohistochemical analysis, and real-time PCR to examine the time-dependent changes in expression levels of proteins and mRNA, related to cell cycle and cellular senescence markers, in the cerebrum during the initial 14 days after TBI using a mouse model of controlled cortical impact (CCI). Within the area adjacent to the cerebral contusion after TBI, the protein and/or mRNA expression levels of cell cycle markers were increased significantly until 4 days after injury and senescence markers were significantly increased at 4, 7, and 14 days after injury. Our findings suggested that TBI initially activated the cell cycle in neurons, astrocytes, and microglia within the area adjacent to the hemicerebrum contusion in TBI, whereas after 4 days, such cells could undergo senescence in a cell-type-dependent manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0213673

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Senescence-associated-β-galactosidase (SA-β-gal) staining in the cerebrum 1 to 14 days after injury. (A) SA-β-gal-positive cells could be observed in the ipsilateral cerebrum at 1, 4, 7, and 14 days after injury in injury groups. Scale = 100 μm. (B) Stained levels of SA-β-gal-positive cells, digitized for analysis by ImageJ software, in the ipsilateral side of the brain injury in the injury group at 4, 7, and 14 days after injury as compared to that in the corresponding area of the contralateral hemicerebrum of the injury group and the bilateral hemicerebrum of the sham and control groups (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).
Fig 1 Senescence-associated-β-galactosidase (SA-β-gal) staining in the cerebrum 1 to 14 days after injury. (A) SA-β-gal-positive cells could be observed in the ipsilateral cerebrum at 1, 4, 7, and 14 days after injury in injury groups. Scale = 100 μm. (B) Stained levels of SA-β-gal-positive cells, digitized for analysis by ImageJ software, in the ipsilateral side of the brain injury in the injury group at 4, 7, and 14 days after injury as compared to that in the corresponding area of the contralateral hemicerebrum of the injury group and the bilateral hemicerebrum of the sham and control groups (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).CC BY · PubMed Central
Fig 2 Cyclin D1 immunohistochemistry and mRNA expression in the cerebrum 1 to 14 days after injury. (A) Cyclin D1 immunostained cells could be observed in the ipsilateral hemicerebrum at 1, 4, 7, and 14 days after injury in injury groups. Long scale = 50 μm, short scale = 12.5 μm. (B-D) Double immunohistochemistry of the ipsilateral hemicerebrum at 4 days after injury for co-localization of (B) cyclin D1, NeuN, DAPI (4',6-diamidino-2-phenylindole), and merge; (C) cyclin D1, ionized calcium binding adaptor molecule 1 (Iba 1), DAPI, and merge; and (D) cyclin D1, glial fibrillary acidic protein (GFAP), DAPI, and merge. Scale = 30 μm. (E) Graph of the numbers of cyclin D1 immunostained cells from (A). (F-H) Cyclin D1 mRNA expression in the ipsilateral hemicerebrum 1 to 14 days after injury. Expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (F), hypoxanthine guanine phosphoribosyl transferase (Hprt) (G), and peptidylprolyl isomerase A (Ppia) (H) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).
Fig 2 Cyclin D1 immunohistochemistry and mRNA expression in the cerebrum 1 to 14 days after injury. (A) Cyclin D1 immunostained cells could be observed in the ipsilateral hemicerebrum at 1, 4, 7, and 14 days after injury in injury groups. Long scale = 50 μm, short scale = 12.5 μm. (B-D) Double immunohistochemistry of the ipsilateral hemicerebrum at 4 days after injury for co-localization of (B) cyclin D1, NeuN, DAPI (4',6-diamidino-2-phenylindole), and merge; (C) cyclin D1, ionized calcium binding adaptor molecule 1 (Iba 1), DAPI, and merge; and (D) cyclin D1, glial fibrillary acidic protein (GFAP), DAPI, and merge. Scale = 30 μm. (E) Graph of the numbers of cyclin D1 immunostained cells from (A). (F-H) Cyclin D1 mRNA expression in the ipsilateral hemicerebrum 1 to 14 days after injury. Expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (F), hypoxanthine guanine phosphoribosyl transferase (Hprt) (G), and peptidylprolyl isomerase A (Ppia) (H) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).CC BY · PubMed Central
Fig 3 Proliferating cell nuclear antigen (PCNA) immunohistochemistry and mRNA expression in the cerebrum 1 to 14 days after injury. (A) PCNA immunostained cells could be observed in the ipsilateral hemicerebrum at 1, 4, 7, and 14 days after injury in injury groups. Long scale = 50 μm, short scale = 12.5 μm. (B-D) Double immunohistochemistry of the ipsilateral hemicerebrum at 4 days after injury for co-localization of (B) PCNA, NeuN, DAPI (4',6-diamidino-2-phenylindole), and merge; (C) PCNA, ionized calcium binding adaptor molecule 1 (Iba 1), DAPI, and merge; and (D) PCNA, glial fibrillary acidic protein (GFAP), DAPI, and merge. Scale = 30 μm. (E) Graph of the numbers of PCNA immunostained cells in (A). (F-H) Pcna mRNA expression in the ipsilateral hemicerebrum 1 to 14 days after injury. Pcna mRNA expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (F), hypoxanthine guanine phosphoribosyl transferase (Hprt) (G), and peptidylprolyl isomerase A (Ppia) (H) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).
Fig 3 Proliferating cell nuclear antigen (PCNA) immunohistochemistry and mRNA expression in the cerebrum 1 to 14 days after injury. (A) PCNA immunostained cells could be observed in the ipsilateral hemicerebrum at 1, 4, 7, and 14 days after injury in injury groups. Long scale = 50 μm, short scale = 12.5 μm. (B-D) Double immunohistochemistry of the ipsilateral hemicerebrum at 4 days after injury for co-localization of (B) PCNA, NeuN, DAPI (4',6-diamidino-2-phenylindole), and merge; (C) PCNA, ionized calcium binding adaptor molecule 1 (Iba 1), DAPI, and merge; and (D) PCNA, glial fibrillary acidic protein (GFAP), DAPI, and merge. Scale = 30 μm. (E) Graph of the numbers of PCNA immunostained cells in (A). (F-H) Pcna mRNA expression in the ipsilateral hemicerebrum 1 to 14 days after injury. Pcna mRNA expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (F), hypoxanthine guanine phosphoribosyl transferase (Hprt) (G), and peptidylprolyl isomerase A (Ppia) (H) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).CC BY · PubMed Central
Fig 4 Cyclin-dependent kinase inhibitor 2A (p16) immunohistochemistry and mRNA expression in the cerebrum 1 to 14 days after injury. (A) p16 immunostained cells could be observed in the ipsilateral hemicerebrum at 4, 7, and 14 days after injury in injury groups. Long scale = 50 μm, short scale = 12.5 μm. (B) Double immunohistochemistry of the ipsilateral hemicerebrum at 7 days after injury for co-localization of p16, glial fibrillary acidic protein (GFAP), DAPI (4',6-diamidino-2-phenylindole), and merge. Scale = 30 μm. (C) Graph of the numbers of p16 immunostained cells in the ipsilateral hemicerebrum in (A). (D-F) p16 mRNA expression in the ipsilateral hemicerebrum 1 to 14 days after injury. p16 mRNA expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (D), hypoxanthine guanine phosphoribosyl transferase (Hprt) (E), and peptidylprolyl isomerase A (Ppia) (F) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).
Fig 4 Cyclin-dependent kinase inhibitor 2A (p16) immunohistochemistry and mRNA expression in the cerebrum 1 to 14 days after injury. (A) p16 immunostained cells could be observed in the ipsilateral hemicerebrum at 4, 7, and 14 days after injury in injury groups. Long scale = 50 μm, short scale = 12.5 μm. (B) Double immunohistochemistry of the ipsilateral hemicerebrum at 7 days after injury for co-localization of p16, glial fibrillary acidic protein (GFAP), DAPI (4',6-diamidino-2-phenylindole), and merge. Scale = 30 μm. (C) Graph of the numbers of p16 immunostained cells in the ipsilateral hemicerebrum in (A). (D-F) p16 mRNA expression in the ipsilateral hemicerebrum 1 to 14 days after injury. p16 mRNA expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (D), hypoxanthine guanine phosphoribosyl transferase (Hprt) (E), and peptidylprolyl isomerase A (Ppia) (F) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).CC BY · PubMed Central
Fig 5 Cyclin-dependent kinase inhibitor 1A (p21) immunohistochemistry and mRNA expression in the cerebrum 1 to 14 days after injury. (A) p21 immunostained cells could be observed in the ipsilateral hemicerebrum at 1, 4, 7, and 14 days after injury in injury groups. Long scale = 50 μm, short scale = 12.5 μm. (B, C) Double immunohistochemistry of the ipsilateral hemicerebrum at 7 days after injury for co-localization of (B) p21, NeuN, DAPI (4',6-diamidino-2-phenylindole), and merge; and (C) p21, ionized calcium binding adaptor molecule 1 (Iba 1), DAPI, and merge. Scale = 30 μm. (D) Graph of the numbers of p21 immunostained cells in the ipsilateral hemicerebrum in the injury group at 1 to 14 days after injury in (A). (E-G) p21 mRNA expression in the ipsilateral hemicerebrum 1 to 14 days after injury. p21 mRNA expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (E), hypoxanthine guanine phosphoribosyl transferase (Hprt) (F), and peptidylprolyl isomerase A (Ppia) (G) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).
Fig 5 Cyclin-dependent kinase inhibitor 1A (p21) immunohistochemistry and mRNA expression in the cerebrum 1 to 14 days after injury. (A) p21 immunostained cells could be observed in the ipsilateral hemicerebrum at 1, 4, 7, and 14 days after injury in injury groups. Long scale = 50 μm, short scale = 12.5 μm. (B, C) Double immunohistochemistry of the ipsilateral hemicerebrum at 7 days after injury for co-localization of (B) p21, NeuN, DAPI (4',6-diamidino-2-phenylindole), and merge; and (C) p21, ionized calcium binding adaptor molecule 1 (Iba 1), DAPI, and merge. Scale = 30 μm. (D) Graph of the numbers of p21 immunostained cells in the ipsilateral hemicerebrum in the injury group at 1 to 14 days after injury in (A). (E-G) p21 mRNA expression in the ipsilateral hemicerebrum 1 to 14 days after injury. p21 mRNA expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (E), hypoxanthine guanine phosphoribosyl transferase (Hprt) (F), and peptidylprolyl isomerase A (Ppia) (G) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).CC BY · PubMed Central
Fig 6 mRNA expression of the transformation related protein 53 (p53) in the ipsilateral hemicerebrum 1 to 14 days after injury. p53 mRNA expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (A), hypoxanthine guanine phosphoribosyl transferase (Hprt) (B) and peptidylprolyl isomerase A (Ppia) (C) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).
Fig 6 mRNA expression of the transformation related protein 53 (p53) in the ipsilateral hemicerebrum 1 to 14 days after injury. p53 mRNA expressions were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (A), hypoxanthine guanine phosphoribosyl transferase (Hprt) (B) and peptidylprolyl isomerase A (Ppia) (C) (*p < 0.05, n = 5 for control group, n = 5 for the sham group, n = 5 for the injury group).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. N Ohtani, 2015, Two faces of cellular senescence—SASP may promotes inflammation and cancer, Journal of Clinical and Experimental Medicine, 253, 753

Cited by

See all 67

Metadata

Authors
Tominaga, T., Shimada, R., Okada, Y., Kawamata, T., & Kibayashi, K.
Affiliations
  • Tokyo Women's Medical University (JP)
  • St. Luke's International Hospital (JP)
Corresponding author
Shimada, Ryo
Venue
PLOS ONE
Published
2019-03-11
Volume
14
Issue
3
Pages
e0213673
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2921980535
Cited by
66
References
37
Citations by year
2026: 5 · 2025: 6 · 2024: 11 · 2023: 13 · 2022: 8 · 2021: 14 · 2020: 5 · 2019: 4
FWCI
5.23
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
Japan Society for the Promotion of Science (16K09220, 19H03917)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
Keywords
traumatic brain injury, cellular senescence, senescence-associated β-galactosidase, controlled cortical impact, cerebral contusion, cell cycle markers, senescence-associated secretory phenotype, DNA damage response, neurons, astrocytes, microglia, mouse model
MeSH terms
Brain Injuries, Traumatic, Animals, Autophagy, beta-Galactosidase, Disease Models, Animal, Male, Mice, Inbred C57BL, Neurons, Signal Transduction, Cellular Senescence, Apoptosis, Proliferating Cell Nuclear Antigen, Cyclin D1, Gene Expression Profiling, Mice, Cerebrum

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.